Tsung-Wen Chong
Affiliations: | 2000-2004 | University of Oxford, Oxford, United Kingdom |
Google:
"Tsung-Wen Chong"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lim CJ, Nguyen PHD, Wasser M, et al. (2020) Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer. Frontiers in Immunology. 11: 615091 |
| Yuen JS, Sim MY, Sim HG, et al. (2012) Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma. International Journal of Oncology. 41: 712-20 |
| Silk JD, Hermans IF, Gileadi U, et al. (2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. The Journal of Clinical Investigation. 114: 1800-11 |
| Hermans IF, Chong TW, Palmowski MJ, et al. (2003) Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. Cancer Research. 63: 8408-13 |
| Chong TW, Horwitz LD, Moore JW, et al. (2002) A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines. Cancer Research. 62: 6924-7 |